- Study: China outpaces the US in cancer approvals, lags behind on first approvals<p>While China's National Medical Products Administration (NMPA) approved more oncology drugs compared to the US Food and Drug Administration (FDA) from 2020 to 2025, the US regulator approved more…raps · 4d ago↗ source
- MHRA touts uptick in approvals in 2025-2026 annual report<p>The UK's Medicines and Healthcare products Regulatory Agency (MHRA) touted its achievements over the last year its 2025-2026 annual report to Parliament, which includes approving more new drugs…raps · 4d ago↗ source
- Opinion: Beware the unintended consequences of testosterone screening for military servicemembers“I fear that the widespread rollout of testosterone screening may lead to some surprising and unintended consequences,” writes a urologist who studies testosterone.